2017
DOI: 10.1021/acs.analchem.7b00813
|View full text |Cite
|
Sign up to set email alerts
|

Inhibiting Firefly Bioluminescence by Chalcones

Abstract: Chalcone refers to an aromatic ketone and an enone that constitutes the central core for various important biological compounds in drug discovery. Moreover, the firefly luciferase (Fluc) as the bioluminescent reporter has been widely used in life science research and high-throughput screening (HTS). However, Fluc might suffer from direct inhibition by HTS compounds resulting in the occurrence of "false positives." In the current research, we discovered a series of chalcone compounds as Fluc inhibitors with fav… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
16
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(18 citation statements)
references
References 39 publications
2
16
0
Order By: Relevance
“…As shown in Figure 6A , in 50–200 μM range a complete inhibition on hSIRT1 by both resveratrol and quercetin was observed when the bioluminescent assay was applied. A complete inhibition was observed also by using the non-acetylated control substrate (data not shown), thus allowing to exclude a direct inhibition of resveratrol and quercetin on hSIRT1; conversely, the observed effect can depend on the capability of resveratrol and flavonoids to inhibit the firefly luciferase activity ( Bakhtiarova et al, 2006 ; Auld et al, 2008 ; Zhang et al, 2017 ). A similar behavior was observed also for WM-SRT ( Figure 6B ).…”
Section: Resultsmentioning
confidence: 86%
See 1 more Smart Citation
“…As shown in Figure 6A , in 50–200 μM range a complete inhibition on hSIRT1 by both resveratrol and quercetin was observed when the bioluminescent assay was applied. A complete inhibition was observed also by using the non-acetylated control substrate (data not shown), thus allowing to exclude a direct inhibition of resveratrol and quercetin on hSIRT1; conversely, the observed effect can depend on the capability of resveratrol and flavonoids to inhibit the firefly luciferase activity ( Bakhtiarova et al, 2006 ; Auld et al, 2008 ; Zhang et al, 2017 ). A similar behavior was observed also for WM-SRT ( Figure 6B ).…”
Section: Resultsmentioning
confidence: 86%
“…These compounds have been reported as potent hSIRT1 activators ( Howitz et al, 2003 ), but with respect to their activation mechanism inconsistent and conflicting findings have been reported ( Hubbard and Sinclair, 2014 ). The combinatory use of bioluminescence/HTRF ® sirtuin assays proved to be crucial in identifying the false inhibition effect of both tested compounds shown by SIRT-Glo TM assay, which actually may be attributed to the capability of resveratrol and flavonoids to inhibit the firefly luciferase activity ( Bakhtiarova et al, 2006 ; Auld et al, 2008 ; Zhang et al, 2017 ). Interestingly, by using HTRF ® assay no effect of resveratrol was observed on both WM-SRT and hSIRT1 activities, while only a slight increase, up to about 20%, of hSIRT1 activity by quercetin was observed, much lower than that reported in previous studies using Fluor de Lys assay ( Howitz et al, 2003 ; de Boer et al, 2006 ).…”
Section: Discussionmentioning
confidence: 99%
“…In 2017, Zhang et al found that a series of chalcone compounds were identified as Fluc inhibitors with favorable potency both in vitro and in vivo. 11 Resveratrol, which shows therapeutic potential in patients with cancer, diabetes, and Alzheimer's disease, has been identified as a potent inhibitor of FLuc (K i = 2 μM). 12 Resveratrol's activity reported by most studies is basically at the level of micromolar, but many of these studies utilized the FLuc assay.…”
Section: ■ Introductionmentioning
confidence: 99%
“…For example, chalcone refers to an aromatic ketone and an enone which has exhibited a broad range of therapeutic activity, such as anticancer, antiparasitic, anti-HIV, and so on. In 2017, Zhang et al found that a series of chalcone compounds were identified as Fluc inhibitors with favorable potency both in vitro and in vivo . Resveratrol, which shows therapeutic potential in patients with cancer, diabetes, and Alzheimer’s disease, has been identified as a potent inhibitor of FLuc ( K i = 2 μM) .…”
Section: Introductionmentioning
confidence: 99%
“…The naturally available chalcones play a beneficial role in anti‐cancer activity, bioluminescence and active plant resistance of biological applications. However, the synthetic chalcone monomers have attractive features in host–guest chemistry and optical applications.…”
Section: Introductionmentioning
confidence: 99%